14-3-3 sigma or stratifin (SFN), found to be dually located in this work, has shown aberrant expression in various cancers, being often downregulated, but its upregulation has been associated with the development of resistance to therapeutic drugs and ECM remodeling (Aljabal and Yap, 2020). Here, SFN is linked to cancer.